Ensign Peak Advisors, Inc
Position in SRRK — Scholar Rock Holding Corp
CIK 1454984
SALT LAKE CITY, UT
Position in SRRK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$35,260,157
-$1,559,079 QoQ
Shares Held
717,253
-14.2% QoQ
Ownership
0.599%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,687 across 116 Biotechnology names. SRRK ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
This page
|
717,253 | $35,260,157 |
All Filings in SRRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,260,157 | 717,253 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $36,819,236 | 835,851 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,289,268 | 652,236 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,274,633 | 600,639 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,800,663 | 335,946 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,124,236 | 187,974 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $312,181 | 38,974 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $324,653 | 38,974 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $692,178 | 38,974 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $769,672 | 40,940 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $290,674 | 40,940 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $277,019 | 36,740 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $246,720 | 30,840 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $221,182 | 24,440 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $126,056 | 18,190 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $135,877 | 24,750 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $164,218 | 12,740 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $316,461 | 12,740 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $409,252 | 14,161 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $717,396 | 14,161 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $295,013 | 6,079 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||